Comparative risk of musculoskeletal adverse reactions among new users of dipeptidyl peptidase-4 inhibitors: A retrospective cohort study

Taehwan Park, Maureen Bresnahan, Scott K. Griggs, Jiajing Chen, Alex H. Cho, Yolene Gousse, Mark Feinglos

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number100022
JournalExploratory Research in Clinical and Social Pharmacy
Volume2
DOIs
StatePublished - Jun 2021

ASJC Scopus Subject Areas

  • Health, Toxicology and Mutagenesis
  • Pharmacology (medical)
  • Pharmacy

Keywords

  • Comparative risk
  • DPP4 inhibitors
  • Musculoskeletal adverse reactions
  • Pharmacoepidemiology

Cite this